Open AccessLong-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist
Author(s) -
Aart Jan van der Lely,
R. Kent Hutson,
Peter Trainer,
G. M. Besser,
Ariel L. Barkan,
Laurence Katznelson,
Anne Klibanski,
Vivien S. Herman-Bonert,
Shlomo Melmed,
Mary Lee Vance,
Pamela U. Freda,
Paul M. Stewart,
Keith Friend,
David R. Clemmons,
Gudmundur Johannsson,
Stavros Stavrou,
David M. Cook,
Lawrence Phillips,
Christian J. Strasburger,
Suzanne Hackett,
Kenneth A. Zib,
Robert J. Davis,
John A. Scarlett,
Michael O. Thorner
Publication year - 2001
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/82mk-gm08
Subject(s) - pegvisomant , acromegaly , antagonist , endocrinology , medicine , term (time) , growth hormone , receptor , hormone , pharmacology , physics , quantum mechanics